 |
September 02, 2010
Dr Bernardo Bonanni - European Institute of Oncology, Milan, Italy, speaking at the 12th Milan Breast Cancer Conference, June 2010. High risk clinic: follow-up of healthy individuals with genetic ...
|
 |
September 02, 2010
Dr Andrea Decensi, Medical Oncology Unit, Galliera Hospital, Genoa, Italy, speaking at the 12th Milan Breast Cancer Conference, June 2010: Metabolic syndrome and breast cancer prevention. ...
|
 |
September 02, 2010
Prof Norbert Avril talking at the 12th Milan Breast Cancer Conference, June 2010 : PET scans in staging and treatment of breast cancer.
|
 |
August 17, 2010
Prof Caldas discusses his research which has revealed that women who had a bad prognosis at time of breast cancer diagnosis but have survived for five years have a much better chance of survival ...
|
 |
August 17, 2010
Dr Balmain speaks to ecancer.tv about his work identifying individuals who are highly susceptible to cancer. Dr Balmain discusses what information is used to determine cancer susceptibility in ...
|
 |
August 17, 2010
Dr Jones speaks to ecancer.tv about the way epigenetics can be used to treat cancer, the progress that has been made in this field and the potential to use this technology to treat solid tumours. ...
|
 |
August 17, 2010
Prof Esteller explains how epigenetics can be used to treat cancer. Prof Esteller’s lab has been working to find new genes that undergo epigenetic inactivation in cancer cells, carry out ...
|
 |
August 17, 2010
Prof Helleday speaks about his work on the PARP inhibitors, how these can selectively kill recombination defective tumour cells and discusses the significance of homologous recombination in the ...
|
 |
August 17, 2010
Prof van de Vijver discusses his work identifying genes that can be used to predict response to breast cancer treatment. Gene expression profiles of tumour samples are used to identify which genes ...
|
 |
August 17, 2010
Prof Helin speaks about his work using epigenetics to identify specific new targets for cancer therapy. Although the drugs Prof Helin is working on have not yet entered clinical trials, the ...
|
 |
August 17, 2010
Prof Marais speaks about his research into the genetic influence of the B-RAF mutation in melanoma. Using mice as models for the disease, Prof Marais' team have been working to identify ...
|
 |
August 17, 2010
Prof Celis talks about the need for all stakeholders to work together to direct European cancer policy. To this end, ECCO have set up the European Academy of Cancer Sciences, a group of ...
|
 |
August 17, 2010
Prof Arnold Levine speaks about his work investigating the p53 gene and p53 protein. Cancer is often caused by mutation of a number of genes. Prof Levine explains how inactivation of these mutated ...
|
 |
August 15, 2010
Dr Bertolini speaks to ecancer.tv about his research into anti-angiogenic therapy as treatment for breast cancer. Anti-angiogenic therapy has been successful increasing progression free survival, ...
|
 |
August 15, 2010
Prof Rath speaks about the challenges faced trying to reduce the number of preventable cancer cases in India. The majority of these, 45% of the three million cancer cases being treated at any one ...
|
 |
August 15, 2010
Dr Sahni talks to ecancer.tv about the increased incidence of breast cancer in India. Although India does not have a national screening programme, there are programmes teaching women the ...
|
 |
August 05, 2010
Prof Goldman discusses the recent developments in the treatment of chronic myeloid leukaemia, specifically the results of using 2nd generation tyrosine kinase inhibitors for treatment of chronic ...
|
 |
August 05, 2010
Dr Bullinger discusses the use of genomics technologies in acute myeloid leukaemia, in particular, the use of DNA microarrays. Microarrays are used as diagnostic tools to identify different ...
|
 |
August 05, 2010
Dr Fielding discusses data from UKALL 12, a trial for adults with acute lymphoblastic leukaemia. Part of the trial evaluated the addition of the tyrosine kinase inhibitor, imatinib, to standard ...
|
 |
August 03, 2010
Dr Cornes talks about how Cochrane groups benefit clinicians and discusses the alarming rise in endometrial cancer rates in the last decade. The increase has been attributed to our aging ...
|
|
|
|
|
|
Featured
Content
Featuring websites that enhance the internet user’s experience.
|